Assessment of hormone receptor expression is most useful for this distinction, as the gastric-type cervical adenocarcinomas are typically ER and PR negative whereas endometrial mucinous adenocarcinomas and endometrioid adenocarcinomas with mucinous differentiation are characteristically hormone receptor positive. Here, NR4A1 is linked to endometrioid adenocarcinoma.